White Paper

Key Considerations For Selecting Fill/Finish Manufacturing Technologies

By Eleftherios Hristofas, Manager, R&D Pharma Processing, West Pharmaceutical Services

Vials pharma manufacturing GettyImages-618518692

The growing pipeline of biologics, increase in vaccine production, and trends toward smaller batch sizes to serve smaller patient populations are increasing demand for advanced manufacturing technologies. These parenteral drugs require advanced facilities and equipment for fill/finish operations to ensure product quality and safety.

Manufacturing planning is a critical step in the path to commercialization and helps companies accelerate their path to market. As pharmaceutical, biotech companies, and contract development and manufacturing organizations (CDMOs) look to build or expand manufacturing capabilities, they must consider strategies for maximization of floorspace, reduced risk of cross-contamination, manufacturing flexibility, varying throughput, tech transfer, and various primary packaging formats.

Obtaining information and proactively mapping out your approach early to better understand the decisions you need to make around your fill/finish strategy can de-risk an investment in equipment or processes, ensuring you meet your long-term needs.

access the White Paper!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Supply Leader? Subscribe today.

Subscribe to Clinical Supply Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Clinical Supply Leader

West Pharmaceutical Services, Inc.